Clinical Trial Update: Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial update on topical paromomycin for cutaneous leishmaniasis in Bolivia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leishmania Braziliensis Complex
• Leishmaniasis American
• Leishmaniasis American Cutaneous
• Leishmaniasis Cutaneous

Drugs mentioned

• Paromomycin (paromomycin)

Snippet

Sponsor: Fundacion Nacional de Dermatologia | Conditions: Leishmaniasis, Cutaneous, Leishmania Braziliensis Complex | Phase 2, Phase 3 | Status: COMPLETED